Expert: MDMA-Assisted Therapy Has Potential Benefits for Women with Hypoactive Sexual Desire Disorder

Video

Kelsey Ramsden, CEO of Mind Cure Health, said research into the use of MDMA-assisted therapy could have a huge impact on the treatment of female hypoactive sexual desire disorder.

In part 1 of an interview with Pharmacy Times, Kelsey Ramsden, CEO of Mind Cure Health, said research into the use of MDMA-assisted therapy could have a huge impact on the treatment of female hypoactive sexual desire disorder.

Mind Cure Health has launched The Desire Project, which is investigating the potential use of MDMA-assisted psychotherapy for the treatment of female hypoactive sexual desire disorder. In the interview, Ramsden discussed how sexual health is directly linked with mental health, how MDMA-assisted psychotherapy could be used to treat the disorder, and why the Desire Project is directly focusing on women.

Related Videos
Opill manufacturing | Perrigo
Image Credit: Adobe Stock - nataliaderiabina
Image credit: InsideCreativeHouse | stock.adobe.com
Image Credit: SciePro - stock.adobe.com
Pharmacist selling medications in the pharmacy | Image Credit: rh2010 - stock.adobe.com
Whole psilocybin mushroom in a clear medication capsule | Image credit: Zim - stock.adobe.com
Image credit: Melita - stock.adobe.com
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская | stock.adobe.com
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Image credit: alicja neumiler | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.